Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Collection of Clinical and Imaging Data, Radiotherapy Planning and Biomaterials for Integrated Analysis of Therapy Response and Resistance and Detection of Molecular Targets in Adolescents and Young Adults With CNS Tumors

NCT06323408 is registered in ClinicalTrials.gov with University Hospital Regensburg as lead sponsor.

NCT NCT06323408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06323408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Collection of Clinical and Imaging Data, Radiotherapy Planning and Biomaterials for Integrated Analysis of Therapy Response and Resistance and Detection of Molecular Targets in Adolescents and Young Adults With CNS Tumors
Lead sponsor
University Hospital Regensburg
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2025
Completion date
March 31, 2026
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

embryonal tumor, ependymoma, glioma, malignant, medulloblastoma